Nativo Wins Gold for Best Use of Native Advertising at the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nativo Wins Gold for Best Use of Native Advertising at the Industry's Renowned Pearl Awards Gala in NYC

LOS ANGELES, CA--(Marketwired - Nov 30, 2015) - Nativo, the leading native advertising platform, received top honors by The Content Council with a Gold award for Best Use of Native Advertising at the annual Pearl Awards in New York City. Nativo was the only technology solutions provider recognized among The Pearl Awards' brand and publisher winners. This award recognizes Nativo's collaboration with Horizon Media and HISTORY Channel for their engaging branded content campaign for the reality series The Curse of Oak Island .

"I'm very proud of the innovation we've achieved together with Horizon Media and HISTORY, and being recognized by The Content Council," said Justin Choi, CEO at Nativo. "Nativo remains dedicated to enabling both brands and publishers to create engaging, non-interruptive user experiences. Our work with HISTORY represents a perfect example of how true native advertising can serve to align brand goals with user experience, while delivering value to loyal consumers." 

Nativo's platform enabled HISTORY to scale The Curse of Oak Island's true native campaign. With this campaign, HISTORY delivered fully integrated brand content experiences within each of their publisher partner's organic content environment, and leveraged Nativo's real-time dynamic optimization technology to reach the most receptive audiences with the right creative assets. As a result, HISTORY achieved an overall campaign click-through rate of 59% over benchmark, and average time spent on content 44% over benchmark.

The Pearl Awards celebrate the best in content marketing from around the world. Winners were picked from nearly 500 entries from leading brands, publishers and agencies. Experts judged entries simultaneously in five different locations on overall effectiveness, creativity, visual captivation, and more.

"The array of submissions we received this year made the judging process difficult," said Andy Seibert, Chairman of The Content Council and Managing Partner of Imprint. "This year's nominees encapsulated the evolution of the content marketing industry, putting forward campaigns that exemplify strategic innovation and adept execution."

For more information about The Content Council and the Pearl Awards, visit http://thecontentcouncil.org/Event/Pearl-Awards-2015 .

About Nativo Nativo is the leading advertising technology platform for brand advertisers and publishers to scale, automate, and measure native ads. For brands, Nativo is the ultimate content marketing platform that delivers native content with unparalleled reach, engagement, and intelligence. For media companies, Nativo provides a complete native ad solution that makes it easier to sell, deploy, and optimize native ads across sites and across screens. Nativo combines a dynamic content management system with advanced content ad serving capabilities, allowing publishers to create, manage, and monetize truly native executions without compromising their users' experience. More than 400 brands and 400 publishers leverage Nativo's platform to power their next-generation digital advertising. Learn more at www.nativo.net .

About The Content Council The Content Council is the premier, non-profit organization representing content marketers globally as the definitive resource for content marketing insights and thought leadership; it is focused on promoting the growth and vitality of this dynamic marketing discipline. The Content Council is also an excellent resource for connecting brand marketers with the best content agency to meet their specific needs. Through creativity and strategy, its members build content programs that deliver results. For more information, please visit: www.thecontentcouncil.org

Media Contact Nikki Reyes WIT Strategy for Nativo (408) 499-0033 nreyes@witstrategy.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading